JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

Natalizumab-treated patients have a higher risk of developing progressive multifocal leukoencephalopathy. Exposure to John Cunningham virus (JCV) is a prerequisite for PML (progressive multifocal leukoencephalopathy). To assess JCV exposure in multiple sclerosis patients, we performed a serological...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lanzillo, Roberta, Liuzzi, Raffaele, Vallefuoco, Luca, Moccia, Marcello, Amato, Luca, Vacca, Giovanni, Vacchiano, Veria, Portella, Giuseppe, Brescia Morra, Vincenzo
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2014
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4199559/
https://ncbi.nlm.nih.gov/pubmed/25328396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S63295
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires